PROCEPT BioRobotics Corporation
PRCTNASDAQHealthcare● Active
$28.35
+$0.52(+1.87%)
Market Cap$1.6B
P/E Ratio—
52W High$64.92
52W Low$19.35
PROCEPT BioRobotics Corporation（PRCT）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PRCT · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.10B) | ($0.09B) | ($0.11B) | ($0.09B) | ($0.06B) |
| Depreciation & Amort. | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.05B | $0.03B | $0.02B | $0.01B | $0.00B |
| Change in Working Capital | ($0.01B) | ($0.05B) | ($0.03B) | ($0.01B) | ($0.00B) |
| Net Cash from Operations | ($0.05B) | ($0.10B) | ($0.11B) | ($0.08B) | ($0.06B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.00B) | ($0.03B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.01B) | ($0.00B) | ($0.03B) | ($0.00B) | ($0.00B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | $0.01B | $0.18B | $0.17B | $0.00B | $0.26B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.06B) | ($0.10B) | ($0.13B) | ($0.08B) | ($0.06B) |
| FCF Margin %(computed) | -18.94% | -46.16% | -97.81% | -110.69% | -168.03% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解PROCEPT BioRobotics Corporation
关于PROCEPT BioRobotics Corporation（PRCT）现金流量表
PROCEPT BioRobotics Corporation 2025财年经营活动现金流($0.05B)，自由现金流($0.06B)（FCF利润率-18.94%），资本支出($0.01B)。
常见问题
PRCT · 4 问PROCEPT BioRobotics Corporation 2025财年自由现金流($0.06B)，同比up43.7%。
PRCT free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10